TRANSACTUAL CIC

Company limited by guarantee

Company Registration Number:
12772196 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2024

Period of accounts

Start date: 1 August 2023

End date: 31 July 2024

TRANSACTUAL CIC

Contents of the Financial Statements

for the Period Ended 31 July 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

TRANSACTUAL CIC

Directors' report period ended 31 July 2024

The directors present their report with the financial statements of the company for the period ended 31 July 2024

Principal activities of the company

The company's principal activity during the year continued to be educational services.



Directors

The directors shown below have held office during the whole of the period from
1 August 2023 to 31 July 2024

Helen Belcher
Chay Brown
jane francesca fae
Maryam Din
Keyne Rowe Walker


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
23 April 2025

And signed on behalf of the board by:
Name: Helen Belcher
Status: Director

TRANSACTUAL CIC

Profit And Loss Account

for the Period Ended 31 July 2024

2024 2023


£

£
Turnover: 61,964 52,088
Cost of sales: ( 17,690 ) ( 3,437 )
Gross profit(or loss): 44,274 48,651
Administrative expenses: ( 45,092 ) ( 28,270 )
Operating profit(or loss): (818) 20,381
Interest receivable and similar income: 1,176 304
Interest payable and similar charges: ( 2 )
Profit(or loss) before tax: 358 20,683
Tax: ( 223 ) ( 3,993 )
Profit(or loss) for the financial year: 135 16,690

TRANSACTUAL CIC

Balance sheet

As at 31 July 2024

Notes 2024 2023


£

£
Fixed assets
Tangible assets: 3 256 1,133
Total fixed assets: 256 1,133
Current assets
Debtors: 4 750 1,750
Cash at bank and in hand: 38,672 43,789
Total current assets: 39,422 45,539
Creditors: amounts falling due within one year: 5 ( 16,663 ) ( 23,792 )
Net current assets (liabilities): 22,759 21,747
Total assets less current liabilities: 23,015 22,880
Total net assets (liabilities): 23,015 22,880
Members' funds
Profit and loss account: 23,015 22,880
Total members' funds: 23,015 22,880

The notes form part of these financial statements

TRANSACTUAL CIC

Balance sheet statements

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 23 April 2025
and signed on behalf of the board by:

Name: Helen Belcher
Status: Director

The notes form part of these financial statements

TRANSACTUAL CIC

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from donations and grants received and from the rendering of services. Turnover from donations and grants received is recognised when the funds have been received. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

    Tangible fixed assets depreciation policy

    Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: Office equipment over 3 years

    Other accounting policies

    Debtors Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. Creditors Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. Taxation A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted. Provisions Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably. Foreign currency translation Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

TRANSACTUAL CIC

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 5 5

TRANSACTUAL CIC

Notes to the Financial Statements

for the Period Ended 31 July 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 August 2023 1,490 1,490
Additions
Disposals ( 651 ) ( 651 )
Revaluations
Transfers
At 31 July 2024 839 839
Depreciation
At 1 August 2023 357 357
Charge for year 280 280
On disposals ( 54 ) ( 54 )
Other adjustments
At 31 July 2024 583 583
Net book value
At 31 July 2024 256 256
At 31 July 2023 1,133 1,133

TRANSACTUAL CIC

Notes to the Financial Statements

for the Period Ended 31 July 2024

4. Debtors

2024 2023
£ £
Trade debtors 750 1,750
Total 750 1,750

TRANSACTUAL CIC

Notes to the Financial Statements

for the Period Ended 31 July 2024

5. Creditors: amounts falling due within one year note

2024 2023
£ £
Trade creditors 987 352
Taxation and social security 616 4,460
Other creditors 15,060 18,980
Total 16,663 23,792

TRANSACTUAL CIC

Notes to the Financial Statements

for the Period Ended 31 July 2024

6. Financial Commitments

The following grants were received over the course of the financial year: Stonewall - Transforming Futures 2,285 National Lottery 34,168 £15,060 of the National Lottery Grant was for projects starting in the new financial year.

COMMUNITY INTEREST ANNUAL REPORT

TRANSACTUAL CIC

Company Number: 12772196 (England and Wales)

Year Ending: 31 July 2024

Company activities and impact

During financial year 2023/2024 The Company submitted evidence to a number of consultations, enquiries and calls for evidence. This included responses and contributions to: Just Fair’s submission to the UN Committee on Economic, Social & Cultural Rights NHS England’s Stakeholder and Public Consultations on a new referral pathway for children & young people’s gender incongruence service The Electoral Commission’s Report on the May 2023 local elections in England NHS’s England Interim Clinical Policy Consultation: Puberty suppressing hormones for children and adolescents who have gender incongruence/dysphoria The General Optical Council’s Consultation on removing reference to a registrant’s gender on the public register A joint response (with Trans Media Watch) to the Communications and Digital Committee’s inquiry, The future of news: impartiality, trust and technology. The DfE consultation on Guidance for Schools and Colleges on Gender Questioning Children Healthcare Improvement Scotland’s consultation on Gender identity healthcare services standards The Consultation on changes to the NHS Constitution Our work advocating for trans people during this financial year has also included: Attending regular meetings with NHS Specialised Commissioning. Meeting with MPs and Ministers to ensure they understand trans people’s needs. Taking the Secretary of State for Health and Social Care to judicial review in a dispute over legality of the emergency ban on puberty blockers. We have continued to use our social media channels and website to provide insight into the lived experiences of trans people from a wide range of backgrounds, as well as providing information for community members and our wider society. This financial year, we also migrated our website and reviewed its user experience. The Company published ‘What Do I Need To Know About Surgery?’ This resource for trans people who are in the process of accessing transition-related surgery was funded by the TRANSforming Futures Partnership. They also funded a programme of 4 webinars for healthcare professionals on various aspects of trans people’s healthcare needs. There was good uptake of these webinars and we received positive feedback. Thanks to funding from LGBT Consortium’s Equity Fund, we conducted research into trans people’s healthcare experiences. This research was used to produce our ‘Trans Inclusive Care?’ report, which then informed the development of a resource for hospital staff: ‘Trans Inclusive Hospital Care’. The Company delivered training on trans-inclusion to a number of NHS trusts and ICBs, as well as to other organisations. The Company are active members of the wider sector in which we work and in particularly is regularly engaged with LGBT Consortium, the National LGBT Partnership, National Voices, and the CQC’s Public Engagement Network. We have supported a number of researchers whose research focuses on trans people’s needs – in some instances this has involved being members of the Community Advisory Board or being interviewed for their research, in others we have simply posted their recruitment materials on our social media channels. The Company continues to convene the Trans Health Forum on a quarterly basis, bringing third sector organisations, activists and academics together to network and promote collaboration. Following the announcement of the review into NHS England’s adult gender services, The Company convened the Trans Healthcare Coalition, which is a group of organisations and individuals who are working together to advocate for trans people’s needs within this process. We have continued to seek to engage with the press, although a number of challenges still remain here. Over the course of the financial year, members of the team have made speaking appearances at a range of conferences and events, including a number of LGBTQ+ specific trade union conferences.

Consultation with stakeholders

The Company holds regular meetings with volunteers throughout the year to discuss work programmes, particularly around healthcare and social media. Work plans are developed in conjunction with these volunteer groups. During the development stages of the Company’s ‘What Do I Need To Know About Surgery?’ resource, the Company sought input from the wider trans community. The survey asked people what they wanted to know about transition related surgery, what they wished they’d known, and for top tips for another person pursuing transition-related surgery. The Company also held a focus group to gather additional feedback. The Company consult with medical professionals prior to publishing any resources that may have clinical implications, and we consulted with some individual clinicians on our What Do I Need To Know About Surgery? resource as well as on our Trans Inclusive Hospital Care resource. The Company has an established Legal Advisory Board and consult with lawyers before publishing any resources about rights and protections. The Legal Advisory Board also support strategic decision making in relation to litigation. In June 2024 the Company published ‘Trans Inclusive Care?’ a report on trans people’s experiences when seeking healthcare.

Directors' remuneration

Helen Belcher - £1,852 Chay Brown - £30,510 jane fae - £400 Maryam Din - £415 Keyne Walker - £0

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
18 April 2025

And signed on behalf of the board by:
Name: Chay Brown
Status: Director